Man-Chao Zhang

Man-Chao Zhang

Auto-generated profile, based on publicly available information

Man-Chao Zhang

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2023 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
CGChuandong Geng
Chuandong Geng
MZMan-Chao Zhang
Man-Chao Zhang
GMGaniraju C. Manyam
Ganiraju C. Manyam
JVJody Vykoukal
Jody Vykoukal
JFJohannes Fahrmann
Johannes Fahrmann
TTTimothy C. Thompson
Timothy C. Thompson
Purpose: Speckle-type POZ protein (SPOP) is important in DNA damage response (DDR) and maintenance of genomic stability. Somatic heterozygous missense mutations in the SPOP substrate-binding cleft are found in up to 15% of prostate cancers. While mutations in SPOP predict for benefit from androgen receptor signaling inhibition (ARSi) therapy, outcomes for patients with SPOP-mutant (SPOPmut) prostate cancer are heterogeneous and targeted treatments for SPOPmut castrate-resistant prostate cancer (CRPC) are lacking. Experimental Design: Using in silico genomic and transcriptomic tumor data, proteomics analysis, and genetically modified cell line models, we demonstrate mechanistic links between SPOP mutations, STING signaling alterations, and PARP inhibitor vulnerabilities. Results: We demonstrate that SPOP mutations are associated with upregulation of a 29-gene noncanonical (NC) STING (NC-STING) signature in a subset of SPOPmut, treatment-refractory CRPC patients. We show in preclinical CRPC models that SPOP targets and destabilizes STING1 protein, and prostate cancer–associated SPOP mutations result in upregulated NC-STING–NF-κB signaling and macrophage- and tumor microenvironment (TME)–facilitated reprogramming, leading to tumor cell growth. Importantly, we provide in vitro and in vivo mechanism-based evidence that PARP inhibitor (PARPi) treatment results in a shift from immunosuppressive NC-STING–NF-κB signaling to antitumor, canonical cGAS–STING–IFNβ signaling in SPOPmut CRPC and results in enhanced tumor growth inhibition. Conclusions: We provide evidence that SPOP is critical in regulating immunosuppressive versus antitumor activity downstream of DNA damage–induced STING1 activation in prostate cancer. PARPi treatment of SPOPmut CRPC alters this NC-STING signaling toward canonical, antitumor cGAS–STING–IFNβ signaling, highlighting a novel biomarker-informed treatment strategy for prostate cancer.

16 September 2024
Verified
Other
Open access
CGChuandong Geng
Chuandong Geng
MZMan-Chao Zhang
Man-Chao Zhang
GMGaniraju C. Manyam
Ganiraju C. Manyam
JVJody Vykoukal
Jody Vykoukal
JFJohannes Fahrmann
Johannes Fahrmann
TTTimothy C. Thompson
Timothy C. Thompson
Supplementary Table S6. Quantification of each protein-specific band normalized to vinculin (C4-2b-derived models, Fig. 2B).

16 September 2024
Verified
Other
Open access
CGChuandong Geng
Chuandong Geng
MZMan-Chao Zhang
Man-Chao Zhang
GMGaniraju C. Manyam
Ganiraju C. Manyam
JVJody Vykoukal
Jody Vykoukal
JFJohannes Fahrmann
Johannes Fahrmann
TTTimothy C. Thompson
Timothy C. Thompson
Supplementary Table S9. Quantification of each protein-specific band normalized to vinculin (Dox-inducible C4-2b–derived models, Fig. 4D, upper panel).

16 September 2024
Verified
Other
Open access
CGChuandong Geng
Chuandong Geng
MZMan-Chao Zhang
Man-Chao Zhang
GMGaniraju C. Manyam
Ganiraju C. Manyam
JVJody Vykoukal
Jody Vykoukal
JFJohannes Fahrmann
Johannes Fahrmann
TTTimothy C. Thompson
Timothy C. Thompson
Supplementary Table S5. Complete listing and details of siRNA targeting sequences used for gene knockdown in Fig. 4A and Extended Data Fig. 3.

16 September 2024
Verified
Other
Open access
CGChuandong Geng
Chuandong Geng
MZMan-Chao Zhang
Man-Chao Zhang
GMGaniraju C. Manyam
Ganiraju C. Manyam
JVJody Vykoukal
Jody Vykoukal
JFJohannes Fahrmann
Johannes Fahrmann
TTTimothy C. Thompson
Timothy C. Thompson
Supplementary Table S8. Quantification of each protein-specific band normalized to vinculin (Dox-inducible RM-1-BM– and C4-2b–derived models, Fig. 3A, 3B).

16 September 2024
Verified
Other
Open access
CGChuandong Geng
Chuandong Geng
MZMan-Chao Zhang
Man-Chao Zhang
GMGaniraju C. Manyam
Ganiraju C. Manyam
JVJody Vykoukal
Jody Vykoukal
JFJohannes Fahrmann
Johannes Fahrmann
TTTimothy C. Thompson
Timothy C. Thompson
Supplementary Table S4. Complete listing and details of oligonucleotide primers used for RT-qPCR analysis.